Creative Planning’s Oncolytics Biotech ONCY Stock Holding History

Creative Planning’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.8K	Sell	13,500 -1,045	-7%	-$969	﹤0.01%	4212
2026 Q1	$12.3K	Buy	14,545 +1,215	+9%	+$1.21K	﹤0.01%	4064
2025 Q4	$11.7K	Hold	13,330	–	–	﹤0.01%	3869
2025 Q3	$18.7K	Hold	13,330	–	–	﹤0.01%	3822
2025 Q2	$10.3K	Hold	13,330	–	–	﹤0.01%	3622
2025 Q1	$7.33K	Hold	13,330	–	–	﹤0.01%	3433
2024 Q4	$12.2K	Buy	13,330 +3,000	+29%	+$3.12K	﹤0.01%	3373
2024 Q3	$9K	Buy	+10,330	New	+$10.1K	﹤0.01%	3173
2021 Q2	–	Sell	-170,000	Closed	-$648K	–	2438
2021 Q1	$648K	Sell	170,000 -10,000	-6%	-$29.8K	﹤0.01%	1266
2020 Q4	$428K	Buy	180,000 +10,000	+6%	+$24K	﹤0.01%	1407
2020 Q3	$287K	Buy	170,000 +60,000	+55%	+$110K	﹤0.01%	1441
2020 Q2	$207K	Buy	110,000 +17,000	+18%	+$32K	﹤0.01%	1511
2020 Q1	$128K	Buy	+93,000	New	+$232K	﹤0.01%	1485

Other funds holding ONCY

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Creative Planning's ONCY Position: Q2 2026 in Review

Creative Planning reduced its Oncolytics Biotech (ONCY) stake by 7.2% in Q2 2026, selling an estimated $969 and leaving 13,500 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4212.

Creative Planning first reported a position in ONCY in Q1 2020 and has held it in 13 quarters since. The position peaked at $648K in Q1 2021. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Creative Planning held 13,500 shares of Oncolytics Biotech worth $12.8K as of Q2 2026.
Creative Planning sold 1,045 Oncolytics Biotech shares in Q2 2026, an estimated $969.
Oncolytics Biotech made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4212 holding.
Creative Planning first reported a position in Oncolytics Biotech in Q1 2020 and has held it in 13 quarters since.
Creative Planning's Oncolytics Biotech position peaked at $648K in Q1 2021.
75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.